NivolumabNeuropathic pain and colitis: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1862卷 / 1期

关键词：

D O I：

10.1007/s40278-021-98496-x

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：378 / 378

相关论文

共 50 条

[1] AdalimumabInjection site pain, oesophagitis and aggravated ulcerative colitis: 2 case reports
Reactions Weekly, 2023, 1952 (1) : 28 - 28
[2] SevelamerIschaemic colitis : 2 case reports
Reactions Weekly, 2024, 2019 (1) : 420 - 420
[3] NivolumabHyperthyroidism and colitis: 2 case reports
Reactions Weekly, 2022, 1918 (1) : 390 - 390
[4] IpilimumabAutoimmune colitis: 2 case reports
Reactions Weekly, 2018, 1685 (1) : 114 - 114
[5] PembrolizumabDiarrhoea and colitis: 2 case reports
Reactions Weekly, 2023, 1959 (1) : 539 - 539
[6] GlycerolIschaemic colitis: 2 case reports
Reactions Weekly, 2021, 1848 (1) : 194 - 194
[7] RofecoxibIschaemic colitis: 2 case reports
Reactions Weekly, 2005, 1068 (1) : 12 - 13
[8] LansoprazoleLymphocytic colitis: 2 case reports
Reactions Weekly, 2008, 1185 (1) : 20 - 20
[9] AbataceptUlcerative colitis: 2 case reports
Reactions Weekly, 2014, 1523 (1) : 13 - 13
[10] PembrolizumabRash and colitis: 2 case reports
Reactions Weekly, 2021, 1875 (1) : 285 - 285

← 1 2 3 4 5 →